These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1030 related articles for article (PubMed ID: 18557227)

  • 1. Regulation of dietary supplement advertising: current claims of interest to the Federal Trade Commission, Food and Drug Administration and National Advertising Division.
    Villafranco JE; Lustigman AB
    Food Drug Law J; 2007; 62(4):709-25. PubMed ID: 18557227
    [No Abstract]   [Full Text] [Related]  

  • 2. Disclaimers in dietary supplement print advertising: the bodybuilding category as a model case for change.
    Soller RW; Rice LG; Ambrose PJ
    Food Drug Law J; 2007; 62(2):375-86. PubMed ID: 17632967
    [No Abstract]   [Full Text] [Related]  

  • 3. Ambiguities of the Dietary Supplement Health and Education Act of 1994.
    Pinco RG; Rubin PD
    Food Drug Law J; 1996; 51(3):383-405. PubMed ID: 11797716
    [No Abstract]   [Full Text] [Related]  

  • 4. Dietary supplement labeling and advertising claims: are clinical studies on the full product required?
    Villafranco JE; Bond K
    Food Drug Law J; 2009; 64(1):43-67. PubMed ID: 19998572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of dietary supplements: five years of DSHEA.
    Khatcheressian LA
    Food Drug Law J; 1999; 54(4):623-44. PubMed ID: 11824458
    [No Abstract]   [Full Text] [Related]  

  • 6. From herbal Prozac to Mark McGwire's tonic: how the Dietary Supplement Health and Education Act changed the regulatory landscape for health products.
    Kaczka KA
    J Contemp Health Law Policy; 2000; 16(2):463-99. PubMed ID: 10970182
    [No Abstract]   [Full Text] [Related]  

  • 7. Anticipating new consumer protection challenges in the food and drug marketplace.
    Parnes LB
    Food Drug Law J; 2008; 63(2):593-9. PubMed ID: 18561480
    [No Abstract]   [Full Text] [Related]  

  • 8. The Federal Trade Commission's regulation of weight-loss advertising claims.
    Correia E
    Food Drug Law J; 2004; 59(4):585-94. PubMed ID: 15875353
    [No Abstract]   [Full Text] [Related]  

  • 9. The end of paternalism: a new approach to food labeling.
    Steinborn SB; Todd KA
    Food Drug Law J; 1999; 54(3):401-22. PubMed ID: 11797706
    [No Abstract]   [Full Text] [Related]  

  • 10. Health-benefit claims for probiotic products.
    Heimbach JT
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S122-4; discussion S144-51. PubMed ID: 18181716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STOPPING DECEPTIVE HEALTH CLAIMS: THE NEED FOR A PRIVATE RIGHT OF ACTION UNDER FEDERAL LAW.
    Hoffmann D; Schwartz J
    Am J Law Med; 2016; 42(1):53-84. PubMed ID: 27263263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Who will hear? An examination of the regulation of hearing aids.
    Adams SB
    J Contemp Health Law Policy; 1995; 11(2):505-21. PubMed ID: 10143061
    [No Abstract]   [Full Text] [Related]  

  • 13. The Dietary Supplement Health and Education Act.
    Young AL; Bass IS
    Food Drug Law J; 1995; 50(2):285-92. PubMed ID: 10342995
    [No Abstract]   [Full Text] [Related]  

  • 14. Constitutional protection of commercial speech under the Central Hudson test as applied to health claims.
    Schramm MJ
    Food Drug Law J; 1996; 51(2):323-9. PubMed ID: 11822325
    [No Abstract]   [Full Text] [Related]  

  • 15. The Federal Trade Commission's regulation of advertising claims for dietary supplements.
    Peeler CL; Cohn S
    Food Drug Law J; 1995; 50(3):349-55. PubMed ID: 10343004
    [No Abstract]   [Full Text] [Related]  

  • 16. Re-thinking the dietary supplement laws and regulations 14 years after the Dietary Supplement Health and Education Act implementation.
    Jiang T
    Int J Food Sci Nutr; 2009 Jun; 60(4):293-301. PubMed ID: 19085198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Legal issues concerning the promotion of pharmaceutical products on the internet to consumers.
    Reichertz PS
    Food Drug Law J; 1996; 51(3):355-65. PubMed ID: 11797712
    [No Abstract]   [Full Text] [Related]  

  • 18. Structure/function claims in dietary supplement labeling: not all of these claims need to be submitted to FDA and accompanied in labeling by the DSHEA disclaimer.
    McNamara SH
    Food Drug Law J; 1999; 54(1):35-42. PubMed ID: 11758558
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of the Federal Trade Commission in advertising health products and services.
    Daynard M
    J Am Coll Dent; 2004; 71(2):24-6. PubMed ID: 15347100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoting functional foods and nutraceuticals on the Internet.
    Taylor SE; Feld HJ
    Food Drug Law J; 1999; 54(3):423-51. PubMed ID: 11797707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 52.